The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression
转录因子ZNF217是乳腺癌进展过程中的预后生物标志物和治疗靶点。
期刊:Cancer Discovery
影响因子:33.3
doi:10.1158/2159-8290.CD-12-0093
Littlepage, Laurie E; Adler, Adam S; Kouros-Mehr, Hosein; Huang, Guiqing; Chou, Jonathan; Krig, Sheryl R; Griffith, Obi L; Korkola, James E; Qu, Kun; Lawson, Devon A; Xue, Qing; Sternlicht, Mark D; Dijkgraaf, Gerrit J P; Yaswen, Paul; Rugo, Hope S; Sweeney, Colleen A; Collins, Colin C; Gray, Joe W; Chang, Howard Y; Werb, Zena